HSPB3 and rhabdomyosarcoma: To further test HSPB3 pro-differentiation effect, we used cells from fusion-negative rhabdomyosarcoma (FN-RMS), the most common soft tissue malignant tumor in children and adolescents, as a model of myogenic-derived cancer cells48.